Bromoacetilalprenololmentan
Изглед
Nazivi | |
---|---|
IUPAC naziv
2-bromo--{N}--[2-[4-[[2-hidroksi- 3-(2-prop-2-enilfenoksi)propil]amino]- 4-metilcikloheksil]propan-2-il]acetamid
| |
Identifikacija | |
3D model (Jmol)
|
|
Abrevijacija | BrAAM |
ChemSpider | |
MeSH | Bromoacetylalprenololmenthane |
| |
Svojstva | |
C24H37BrN2O3 | |
Molarna masa | 481,48 g·mol−1 |
log P | 4,14 |
Kiselost (pKa) | 13,.844 |
Baznost (pKb) | 0,153 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
verifikuj (šta je ?) | |
Reference infokutije | |
Bromoacetilalprenololmentan (BAAM) je beta-adrenergički agonist.[4]
Reference
[уреди | уреди извор]- ^ BrAAM - Compound Summary, PubChem.
- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Rainer-Joachim, Matthys Staehelin (20. 4. 1987). „Bromoacetylalprenololmenthane binding to β-receptors modulates the rate of hormone-induced internalization but not desensitization in S49 cells”. FEBS Letters. 214 (2): 323—326.